Business Wire

SōRSE Technology Partners with & Acquires Part of Cancer Research Group Pascal Biosciences for Cannabinoid Research Programs

“This agreement comes on the heels of recent, successful collaborative efforts with SōRSE that allowed us to examine SōRSE formulations in several Pascal ongoing studies. The combination of SōRSE’s ...
Business Wire

Biotech Company Pascal Biosciences and SōRSE Technology Announce Partnership for Cannabinoid Drug Development and Cancer Clinical Trials

SEATTLE & VANCOUVER, British Columbia--(BUSINESS WIRE)--Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal”) and SōRSE Technology Corporation (“SōRSE”) have entered into a Collaborative Research Agreement ...
Nasdaq

Pascal Biosciences and SōRSE Technology Optimize Cannabinoid Formulation for Clinical Development of Cancer Treatment

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / December 8, 2020 / December 2, 2020 / Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the "Company") and SōRSE Technology Corporation ...
Benzinga.com

SōRSE Technology, Pascal Biosciences To Collaborate On Cannabinoid Programs

Biotechnology company Pascal Biosciences Inc. (TSX.V: PAS) said Wednesday it has signed a term sheet with SōRSE Technology to build up Pascal’s cannabinoid programs. This is the first time SōRSE ...